Stempoint Capital »

Cortexyme shares owned by Stempoint Capital

Quarter-by-quarter ownership of Cortexyme (QNCX) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Cortexyme

Tip: Access up to 7 years of quarterly data

All positions including Cortexyme held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cortexyme by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.5M 739k 3.35

More positions owned by Stempoint Capital

Abivax Sa Sponsored Ads (ABVX)
Scholar Rock Hldg Corp (SRRK)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Syndax Pharmaceuticals (SNDX)
Structure Therapeutics Sponsored Ads (GPCR)
Arcellx Common Stock (ACLX)
Roivant Sciences SHS (ROIV)
Terns Pharmaceuticals (TERN)
Twist Bioscience Corp (TWST)
Immunovant (IMVT)
Dyne Therapeutics (DYN)
Xenon Pharmaceuticals (XENE)
Surrozen Com New (SRZN)
Celcuity (CELC)
Mineralys Therapeutics (MLYS)

View all positions for Stempoint Capital

Top funds holding Cortexyme

Nantahala Capital Management
Vanguard Group
Woodline Partners
Millennium Management
Ieq Capital
Almitas Capital
Superstring Capital Management
Stempoint Capital
Renaissance Technologies
Geode Capital Management
Jane Street
Marshall Wace
BlackRock
Susquehanna International
HighTower Advisors

View all funds holding Cortexyme